Literature DB >> 1980573

Clinical implications of delayed growth of the Lyme borreliosis spirochete, Borrelia burgdorferi.

A B MacDonald1, B W Berger, T G Schwan.   

Abstract

Lyme borreliosis, a spirochetal infection caused by Borrelia burgdorferi, may become clinically active after a period of latency in the host. Active cases of Lyme disease may show clinical relapse following antibiotic therapy. The latency and relapse phenomena suggest that the Lyme disease spirochete is capable of survival in the host for prolonged periods of time. We studied 63 patients with erythema migrans, the pathognomonic cutaneous lesion of Lyme borreliosis, and examined in vitro cultures of biopsies from the active edge of the erythematous patch. Sixteen biopsies yielded spirochetes after prolonged incubations of up to 10.5 months, suggesting that Borrelia burgdorferi may be very slow to divide in certain situations. Some patients with Lyme borreliosis may require more than the currently recommended two to three week course of antibiotic therapy to eradicate strains of the spirochete which grow slowly.

Entities:  

Mesh:

Year:  1990        PMID: 1980573     DOI: 10.1016/0001-706x(90)90047-4

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

2.  Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.

Authors:  B W Berger; R C Johnson; C Kodner; L Coleman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.

Authors:  I Schwartz; G P Wormser; J J Schwartz; D Cooper; P Weissensee; A Gazumyan; E Zimmermann; N S Goldberg; S Bittker; G L Campbell; C S Pavia
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

4.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

Review 5.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

6.  Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.

Authors:  Emir Hodzic; Denise Imai; Sunlian Feng; Stephen W Barthold
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.